TECH vs ZBIO · P/E 65, rev $1.22B vs rev $5.0M
Bio-Techne Corp (TECH) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported ZBIO revenue for 2024-12-31 was $5.0M. Net income was -$157.0M. Revenue was down 90.0% from 2023-12-31 to 2024-12-31. ZBIO currently screens at market cap $798.0M.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the TECH and ZBIO stock pages for the full models.
Not investment advice.